Time in range (TIR) increased from 56.9% at baseline to 88.9%, 76.2% and 71.7% with CagriSema, semaglutide and cagrilintide, respectively [124]
Collectively, these data suggest that expression levels of the uptake and extrusion transporters are not necessarily the limiting factors determining the anti-proliferative effects of metformin and that genetically determined variations in signaling pathways are variably important as are nutrient levels in the tumor microenvironment (249, 254)
The enthusiastic claims circulating online frequently overstate what the research actually shows, and a responsible provider should be candid about the gap between physiologic plausibility and clinical proof
Nutrient IV therapy recipients have reported the following benefits: Stronger immunity
Gut inflammasome activation shows close NAFLD association (93), and combined L-carnitine and vitamin E supplementation upregulated gut inflammasome-related genes while ameliorating liver inflammation and fibrosis in a NASH mouse model (94)
